Cardano Risk Management B.V. Purchases 940 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

by · The Markets Daily

Cardano Risk Management B.V. boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 248,114 shares of the healthcare conglomerate’s stock after acquiring an additional 940 shares during the period. UnitedHealth Group makes up approximately 2.6% of Cardano Risk Management B.V.’s investment portfolio, making the stock its 14th largest holding. Cardano Risk Management B.V.’s holdings in UnitedHealth Group were worth $145,067,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the business. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group during the third quarter worth $27,000. Global Wealth Strategies & Associates lifted its holdings in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares in the last quarter. Macroview Investment Management LLC grew its holdings in shares of UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 47 shares in the last quarter. West Financial Advisors LLC bought a new stake in UnitedHealth Group in the 3rd quarter valued at approximately $32,000. Finally, Bbjs Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $31,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Truist Financial reaffirmed a “buy” rating and issued a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Morgan Stanley lowered their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th. Finally, Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Three investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

Read Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Stock Performance

NYSE UNH opened at $592.23 on Friday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The firm has a 50-day moving average price of $582.84 and a two-hundred day moving average price of $549.52. The company has a market capitalization of $545.02 billion, a P/E ratio of 38.58, a P/E/G ratio of 1.74 and a beta of 0.58. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s revenue was up 9.2% on a year-over-year basis. During the same quarter last year, the company earned $6.56 EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).